Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9066654)

  • 1. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
    Satoh K; Shimosegawa T; Koizumi M; Toyota T
    Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas.
    Gansauge F; Gansauge S; Zobywalski A; Scharnweber C; Link KH; Nussler AK; Beger HG
    Cancer Res; 1995 Dec; 55(23):5499-503. PubMed ID: 7585621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations.
    Tomaszewska R; Nowak K; Stachura J
    Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H
    Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis.
    Givehchian M; Woerner SM; Lacroix J; Zöller M; Drings P; Becker H; Kayser K; Ridder R; von Knebel Doeberitz M
    Oncogene; 1996 Mar; 12(5):1137-44. PubMed ID: 8649806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
    Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
    Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
    Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 in normal human pancreas and pancreatic carcinoma cell lines.
    Ringel J; Jesnowski R; Schmidt C; Ringel J; Köhler HJ; Rychly J; Batra SK; Löhr M
    Teratog Carcinog Mutagen; 2001; 21(1):97-106. PubMed ID: 11135324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?
    Regauer S; Ott A; Berghold A; Beham A
    J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY; Poonja LS
    Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
    Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
    Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive cribriform breast carcinomas in patients with grade 1 and stage IIA (T2 N0 M0) breast cancer strongly express the v3 and v6, but not the v4 isoforms of the metastatic marker CD44.
    Saleh F; Reno W
    Neoplasma; 2008; 55(3):246-55. PubMed ID: 18348657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 variant isoforms in malignant melanoma.
    Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
    Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.